EUVIMEDOdkrijte EUVIMED
Multizentrische StudieOpen access · CC BY 4.0

Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission

Nicolas A Sieben, Sebastiaan Blank iD, Alexis Tabah, Kyle C White iD, Kevin B Laupland iD, Felicity Edwards, Antony Attokaran iD, Stephen Luke, Aashish Kumar iD, Stephen Whebell, Dinesh Parmar, James McCullough and 2 more

Medical Sciences · 2026-05-12 · 14 (2) · 249

DOI: 10.3390/medsci14020249 ↗

At a glance

Multizentrische Studie in Medical Sciences, published online on 2026-05-12. Written by Nicolas A Sieben and 13 co-authors. Institution: Mater Public Hospital, Brisbane, QLD 4101, Australia. Major MEDLINE topics: Diabetic Ketoacidosis, Hypophosphatemia, Critical Care. 33 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

Diabetic ketoacidosis (DKA) is a common complication of diabetes mellitus characterized by metabolic acidosis, ketogenesis, hypovolemia, hyperglycemia, and electrolyte depletion. During treatment of DKA with intravenous fluids and insulin, some electrolyte disturbances can worsen. Hypophosphatemia is one such electrolyte disturbance that has not been well characterized in patients with severe DKA requiring Intensive Care Unit (ICU) admissions. This study sought to evaluate the incidence, severity, associations, and outcomes of hypophosphatemia in DKA.

Methods

This retrospective multicenter study was conducted across DKA admissions to Queensland ICUs from 2016 to 2021. Adult patients (>18 years) requiring ICU admission for management of DKA were included in this study. Patients with DKA were stratified by lowest recorded phosphate level as: normal ≥ 0.80 mmol/L, mild 0.50–0.79 mmol/L, moderate 0.30–0.49 mmol/L and severe < 0.3 mmol/L. Patient demographics, comorbidities, ICU-related supports, and medications (including fluid, insulin administration, phosphate, and other electrolyte replacement) were collected. Univariate analysis was performed between hypophosphatemia severity and normophosphatemia subgroups to determine risk factors, outcomes, replacement, and progression of hypophosphatemia in the ICU. Phosphate replacement and administered insulin was compared to nadir serum phosphate level. Multivariate analysis and linear regression were performed to identify risk factors for the development of hypophosphatemia.

Results

A total of 842 admissions of 669 unique patients due to DKA were included; 436 of 842 (51.8%) admissions maintained normophosphatemia in the ICU, while 220 (26.1%, n = 220/842) had mild hypophosphatemia, 124 (14.7%, n = 124/842) had moderate hypophosphatemia and 62 (7.4%, n = 62/842) had severe hypophosphatemia. Patients with higher BMI, higher APACHE II/III score, cerebrovascular disease and all blood gas parameters (excluding PaO2) were found to have more severe hypophosphatemia. Lower serum phosphate was associated with greater replacement and greater insulin administration per kilogram body weight. ICU length of stay, hospital length of stay and mortality were not affected by degree of hypophosphatemia (p > 0.05). Linear regression revealed that standard base excess was strongly associated with the development of hypophosphatemia (β = 0.02, 95% CI 0.01–0.02, p < 0.001).

Conclusions

Increasing severity of hypophosphatemia was associated with increasing severity of DKA. Increased ICU length of stay was related to increased severity of hypophosphatemia.

Subjects

MeSH terms (MEDLINE)

Diabetic KetoacidosisHypophosphatemiaCritical CareHumansFemaleMaleRetrospective StudiesIntensive Care UnitsMiddle AgedAdultAgedRisk FactorsInsulinPhosphates

Author keywords

diabetesdiabetic ketoacidosiselectrolytesendocrineintensive care

Substances

InsulinPhosphates

Authors and institutions

  • Mater Public Hospital, Brisbane, QLD 4101, Australia.
  • Royal Brisbane and Women's Hospital, Metro North Hospital and Health Services, Brisbane, QLD 4029, Australia.
  • Intensive Care Unit, Cairns Hospital, Cairns, QLD 4870, Australia.
  • Intensive Care Unit, Redcliffe Hospital, Redcliffe, QLD 4020, Australia.
  • Faculty of Medicine, Mayne Academy of Critical Care, University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
  • Intensive Care Unit, Princess Alexandra Hospital, Woolloongabba, QLD 4102, Australia.

ORCID profiles: Sebastiaan Blank, Kyle C White, Kevin B Laupland, Antony Attokaran, Aashish Kumar, Peter Garrett, Mahesh Ramanan

Cite

APA

Sieben, N. A., Blank, S., Tabah, A., White, K. C., Laupland, K. B., Edwards, F., Attokaran, A., Luke, S., Kumar, A., Whebell, S., Parmar, D., McCullough, J., Garrett, P., & Ramanan, M. (2026). Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission. Medical Sciences, 14(2), 249. https://doi.org/10.3390/medsci14020249

Vancouver

Sieben NA, Blank S, Tabah A, White KC, Laupland KB, Edwards F, et al. Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission. Medical Sciences. 2026;14(2):249. doi:10.3390/medsci14020249

BibTeX
@article{Sieben2026,
  author = {Sieben, Nicolas A and Blank, Sebastiaan and Tabah, Alexis and White, Kyle C and Laupland, Kevin B and Edwards, Felicity and Attokaran, Antony and Luke, Stephen and Kumar, Aashish and Whebell, Stephen and Parmar, Dinesh and McCullough, James and Garrett, Peter and Ramanan, Mahesh},
  title = {Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {249},
  doi = {10.3390/medsci14020249}
}
Start for free →